The 20 Best Stomach Cancer Doctors Near Me in Ann Arbor, MI

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma.

Jessica Fried is a Radiologist and an Interventional Radiologist in Ann Arbor, Michigan. Dr. Fried is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Visceromegaly, Alcoholic Cirrhosis, Cholangiocarcinoma (Bile Duct Cancer), and Cirrhosis.

Dr. Donnele Daley is a faculty member within the Section of General Surgery at the University of Michigan.Dr. Daley graduated from Dartmouth College with a Bachelor of Engineering and Vassr College with a Bachelor of Arts in Physics and Mathematics. She graduated with General Honors and was elected into the Phi Beta Kappa Honor Society. She earned her medical degree from Penn State College of Medicine after which she was accepted into the General Surgery Residency program at New York University Medical Center. During her time at NYU, she spent two years in a postdoctoral research fellowship studying tumor immunology and the biology of pancreatic cancer, which fueled her interest in oncology research and cancer care. Upon finishing her General Surgery residency, she completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center in New York.Clinical Specialization:Dr. Daley is a practicing general and oncologic surgeon at the University of Michigan. Her practice encompasses gastrointestinal malignancies and she also specializes in gastric and peritoneal malignancies. Dr. Daley is trained and certified in Minimally Invasive and Robotic Surgery techniques. Dr. Daley is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Stomach Cancer, Pseudomyxoma Peritonei, Gastrointestinal Stromal Tumor, Gastrectomy, and Hernia Surgery.

Oxana Crysler is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Crysler is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. Kwon joined the Division of Gastroenterology in 2005 and is currently a Clinical Professor. He received his bachelor's degree from Amherst College and his medical degree from UCLA Medical School. He completed his internal medicine residency at Cedars-Sinai Medical Center and his gastroenterology fellowship at Brigham and Women's Hospital (BWH). He also completed his advanced endoscopy fellowship at the combined BWH and Massachusetts General Hospital program. He earned his Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr. Kwon is currently the Director of Advanced Endoscopy, Program Director for the Advanced Endoscopy fellowship, and Co-director of the Comprehensive Pancreas Program. He also serves as the Medical Director of the Michigan Chapter of the National Pancreas Foundation. He is a principal investigator in several independently funded research studies and has been an author on over 100 publications, including multiple research studies, national guidelines, and book chapters. He is a sought-after speaker, having served as invited faculty at multiple regional, national and international courses. Dr. Kwon is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Hereditary Pancreatitis, Bile Duct Obstruction, Pancreatic Cancer, Endoscopy, and Lithotripsy.

Arathi Mohan is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Mohan has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Stomach Cancer.

Erik-Jan Wamsteker, MD is a Clinical Associate Professor in the Division of Gastroenterology and Hepatology. Dr. Wamsteker earned his medical degree from UMDNJ Rutgers Medical school (New Jersey Medical School). He completed his internal medicine residency at the University of Michigan and Gastroenterology Fellowship where he focused his training in Advanced Endoscopy with a focus in ERCP and EUS. He is board certified in Gastroenterology.Dr. Wamsteker has authored numerous peer-reviewed articles, abstracts, and book chapters. He has served as a councilor of the AGA Institute Council Pancreatic Disorders Section as well as a counselor to the ACG practice parameters committee tasked with clinical guideline development and serves on the Board of the National Pancreas Foundations Michigan Chapter. He is an active faculty member in the training of GI fellows both for the general GI fellowship as well as Advanced Endoscopy Fellowship programs. He runs the monthly Advanced Endoscopy Conference as well as gives didactic lectures to Internal Medicine residents and GI fellows on various topics focused on endoscopic management of pancreatic and biliary disorders as well as endoscopic oncology.Personal Interests:Music history, listening to music especially on vinyl, print making, greyhounds. Dr. Wamsteker is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Neuroma Biliary Tract, Bile Duct Obstruction, Childhood Pancreatitis, Pancreatectomy, and Gastrectomy.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy.

Andrew C. Chang, M.D., is the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. After completing his undergraduate education at the Massachusetts Institute of Technology and medical education at The Johns Hopkins University he pursued general surgical residency at Vanderbilt University. During this time he also obtained an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with Richard N. Pierson, III, M.D. He then continued as a thoracic surgical resident and subsequently thoracic surgical fellow at the University of Michigan, completing these in 2003, before joining the faculty. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Achalasia, Hiatal Hernia, Hernia, Endoscopy, and Lung Transplant.

Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.Clinical Specialization: Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Lung Cancer, Hiatal Hernia, Esophageal Cancer, Endoscopy, and Lung Transplant.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

James Shields is a Radiologist in Ann Arbor, Michigan. Dr. Shields is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Intussusception in Children, Retroperitoneal Fibrosis, Cerebral Arteriovenous Malformation, Urothelial Cancer, and Gastrostomy.

Dr. William M. Sherk is a board-certified Vascular Interventional Radiologist specializing in venous, lymphatic, and aortic diseases. He is co-lead of the steering committee of the Frankel Cardiovascular Center Venous Health Program, a multidisciplinary team focusing on the care of patients with complex venous problems. Dr. Sherk completed training at the University of Michigan in Interventional Radiology, where he served as Chief Resident. After residency, he joined the faculty at University of Michigan in the division of Interventional Radiology. His research focuses on the diagnosis and multidisciplinary treatments of venous disease, including chronic venous occlusion, cancer-related venous obstruction, and pulmonary embolism. He currently serves as the Program Director for the Integrated Interventional Radiology residency. Dr. Sherk is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Retroperitoneal Fibrosis, Intussusception in Children, May Thurner Syndrome, SVC Obstruction, and Thrombectomy.

Sahira Kazanjian is a Radiologist and an Interventional Radiologist in Ann Arbor, Michigan. Dr. Kazanjian is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Ascites, Retroperitoneal Fibrosis, Intussusception in Children, Thrombectomy, and Bone Marrow Aspiration.

Dr Warhadpande completed his surgical internship and radiology residency at University of Pittsburgh Medical Center (UPMC), where he served as the Chief Resident in his final year. He went on to complete his Vascular and Interventional Radiology (VIR) training at the Medical College of Wisconsin – one of the most decorated and clinical VIR training programs in the country.During his training, Dr Warhadpande was heavily involved in the Society of Interventional Radiology (SIR) and served as the Governing Council Chair of the Resident/Fellow Section. He has published over 20 manuscripts in various journals and has presented at numerous national IR meetings. He is also the co-editor and co-author of one of the best-selling textbooks in interventional radiology, The Pocketbook of Clinical IR: A Concise Guide to Interventional Radiology. At the University of Michigan, Dr Warhadpande has taken a keen interest in providing minimally-invasive pain interventions in the oncologic and non-oncologic patient populations. This includes nerve ablations, soft tissue lesion cryoablations, and bony lesion radiofrequency ablation and cementoplasty.From an endovascular standpoint, Dr Warhadpande’s expertise and research interest is in providing embolotherapy. This is a new frontier in medicine and Dr Warhadpande offers Prostate Artery Embolization (PAE) for Benign Prostatic Hyperplasia, Geniculate Artery Embolization (GAE) for knee osteoarthritis, and Uterine Fibroid Embolization (UFE) for fibroids. Dr. Warhadpande is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Retroperitoneal Fibrosis, Intussusception in Children, Adrenocortical Carcinoma, Gastrostomy, and Vertebroplasty.